OFS Capital Corp (NASDAQ:OFS)’s Chief Executive Officer, R. Glenn Pittson, recently purchased 12, 100 shares of common stock at a price of $12.75 per share. Following the transaction, Pittson owns 57,066 securities directly of the externally managed, closed-end, non-diversified management investment company. R Glenn Pittson also owns 4,000 securities indirectly by daughter at OFS Capital Corp (NASDAQ:OFS). As well, R. Glen Pittson had acquired 5,000 shares at a price of $12.30 each on last May 2014. In addition, last insider investments date of December 2013 when Chief Compliance Officer Eric P. Rubenfeld acquired 1,000 shares at $12.46 per share. Furthermore, Joseph…
Author: M. Paz Lucas
Directors at Checkpoint Systems, Inc. (NYSE:CKP), Keith R Elliot, Iii S William Antle, N Stephen David, W Jack Partridge, Sally Pearson, T Marc Giles, Harald Einsmann newly purchased 8,750 shares of common stock at a price of $12.799 per share. Meanwhile, Director Spicer Julie England got 7,875 shares at $12.799 each. These insiders own, at the time, at least, 17,500 securities each. The largest sharholder amongst them is Mr. Antle, who owns 175,252 shares in the $562.20 Million Market Cap manufacturer and provider of technology-driven loss prevention, inventory management and labeling solutions for the retail and apparel industries. Over the past few months, the company reported several other insider transactions. Furthermore, on the past…
Cross Country Healthcare, Inc. (NASDAQ:CCRN)’s director C Thomas Dircks recently reported an acquisition of 16,000 shares of common stock at a price of $6.34 per share. Following this transaction, Mr. Dircks beneficially owns 56,531 securities of the $209.62 Million Market Cap company. Moreover, Director, President and CEO of the healthcare company, J William Grubbs, also purchased lately an amount of 15,000 shares at $6.36 each. Thus, Mr Grubbs owns at the time 181,044 securities directly. Grubbs previously invested in Cross Country Healthcare, Inc. (NASDAQ:CCRN) on May 2013. In addition, Jim Simons’ Renaissance Technologies displayed an increasing activity as a large…
DSW Inc. (NYSE:DSW)’s Executive Vicepresident, General Counsel & Secretary L William Jordan just reported an acquisition of 1,000 class A common shares at a price of $25.65, on June 3. The total amount of securities that Mr. Jordan directly owns is now 28,928. In addition, on June 2, Senior Vice President E Mary Meixelsperger also purchased an amount of 2,000 shares of common stock at $25.18 per share at the $2.35 Billion Market Cap Retail-Shoe Stores company. Previous insider investments date of May 2011, and were made by B Philip Miller. DSW Inc. also counts with the support of several…
St. Jude Medical, Inc. (NYSE:STJ)’s Directors W John Brown, R Richard Devenuti and K Stefan Widensohler newly received stock awards on the $18 Billion Market Cap company. Each one of them got 1,546 shares of common stock at a price of $64.68 per share. Mr. Brown now owns 134,391 securities directly following this reported transaction, while Mr. Devenuti and Mr. Widensohler own 28,448 and 20,596 respectively. Last insider purchases date of 2012, for John Brown and 2008 for Richard Devenuti. Furthermore, St. Jude Medical, Inc. also counts on several large hedge fund shareholders which layed out increasing activity throughout the…
Imation Corp. (NYSE:IMN)’s Board Director, Iii White L Matthews, reported an acquisition of 70,565 shares on the magnetic and optical recording media company for about $3.72 per share. After this transaction, the insider beneficially owns 266,941 securities directly. White Matthews is the first inside investor this first quarter –and this year, since the last share purchase within the company was made by President and CEO E Mark Lucas on May 2013. Previously, director P David Berg put up and invested on this company one year earlier on may 2012. Imation Corp. (NYSE:IMN) also has large hedge fund investors that displayed increasing…
Uroplasty, Inc. (NASDAQ:UPI)’s director, Kevin H Roche, recently declared a new position in its stock with 10,000 shares common stock. He acquired them for prices ranging from $2.90 per share to $3.02 per share. Following the last reported transaction, Mr. Roche directly owns about 10,000 securities at the surgical and medical instruments and apparatus company. Moreover, on the past few days, Robert Kill, Uroplasty, Inc. (NASDAQ:UPI)’s President and CEO, purchased 500,000 shares at about $3 per share. In addition, several hedge funds are betting on this company. For instance, Nathan Fischel’s Dafna Capital Management, owns 289,332 shares, and Joseph Edelman’s Perceptive Advisors, holds 517,791…